Menu

Indian Institute of Science Education and Research
Thiruvananthapuram

Dr Poonam Thakur
Assistant Professor Grade I (Biology)
  +91 (0)471 - 2778254
  cG9vbmFtQGlpc2VydHZtLmFjLmlu

Key Publications 

  • Rajan A, Varghese A, Hashardeen SP, Babu AN, Vijayan V, Thakur P. Glycated alpha-synuclein assemblies cause distinct Parkinson's disease pathogenesis in mice. ACS Chemical Neuroscience (2025). https://pubs.acs.org/doi/full/10.1021/acschemneuro.5c00428 

  • Subramanya SK, Shekhar S, Kumar DB, Senthil S, Allimuthu D, Luk K, Thakur P.  A Novel Mouse Model of Parkinson’s Disease for Investigating Progressive Pathology and Neuroprotection. bioRxiv; 2025. https://www.biorxiv.org/content/10.1101/2025.02.13.638053v1 

  • Kovacheva L, Shin J, Zaldivar-Diez J, Mankel J, Farassat N, Costa K M, Thakur P, Obeso J, Roeper J. Recovery of the full in vivo firing range in post-lesion surviving DA SN neurons associated with Kv4.3-mediated pacemaker plasticity. eLife, 2025. https://www.biorxiv.org/content/10.1101/2021.08.09.455657v2

  • Hosseini S, Thakur P, Cedeno D, Fereidoni M, Elahdadi Salmani M. Glial Cells in Health and Disease: Impacts on Neural Circuits and Plasticity. Front. Cell. Neurosci. 2025, 19. https://doi.org/10.3389/fncel.2025.1569725. 

  • Thakur P. Mitochondrial calcium homeostasis in synaptic functions. Mitochondria in Neurological Disorders, Academic Press, 2022, ISBN: 9780128217313.

  • Kachappilly N, Srivastava J, Swain BP, Thakur P. Interaction of alpha-synuclein with lipids. Methods in Cell Biology, Academic Press, 2022, ISSN 0091-679X. https://doi.org/10.1016/bs.mcb.2021.12.002.

  • Daniel NH, Aravind A, Thakur P. Are ion channels potential therapeutic targets for Parkinson’s disease? Neurotoxicology (2021), 87:243-257. https://doi.org/10.1016/j.neuro.2021.10.008

  • Thakur P*, Luk K, Roeper J. Selective K-ATP channel-dependent loss of pacemaking in vulnerable nigrostriatal dopamine neurons by α-synuclein aggregates. bioRxiv, 11, 2019. https://www.biorxiv.org/content/10.1101/842344v1 . *Corresponding author

  • Thakur P, Chiu WH, Roeper J, Goldberg JA.  a-Synuclein 2.0 – Moving towards cell-type specific pathophysiology. Neuroscience- Forefront Review (2019),412:248-256. https://doi.org/10.1016/j.neuroscience.2019.06.005

  • Thakur P*, Breger L*, Lundblad M, Wan OW, Mattsson B, Luk K, Lee VM, Trojanowski J, Björklund A. Modeling Parkinson’s disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain. Proceedings of the National Academy of Sciences-PNAS (2017), 114(39): E8284–E8293. https://doi.org/10.1073/pnas.1710442114. * Equal contribution

  • Thakur P and Nehru B. Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of Parkinson’s disease. Molecular Neurobiology (2015), 51(1):209-219. https://doi.org/10.1007/s12035-014-8769-7

  • Thakur P and Nehru B. Long-term heat shock proteins (HSPs) induction by carbenoxolone improves hallmark features of Parkinson’s disease in a rotenone-based model. Neuropharmacology (2014), 79:190-200. https://doi.org/10.1016/j.neuropharm.2013.11.016

  • Thakur P and Nehru B. Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson’s disease pathology. Neurochemistry International (2014), 75:1-10. https://doi.org/10.1016/j.neuint.2014.05.002

  • Thakur P and Nehru B. Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson’s disease. Neuroscience (2013), 12(231):420-431. https://doi.org/10.1016/j.neuroscience.2012.11.006